{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-09-13T12:19:21.680493+00:00",
  "news": [
    {
      "title": "Belpointe Asset Management LLC Has $1.94 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxOdlV3SlRzVDlISGdtZXljQXBwNVZ4VEYwZWFqODJLUWRYZm5TX3M5RTZwMTd2TWFfdkYwSUdwWXJJNEt2X3JyTXZMOUNaTjU5dFdXSU1lSzl3SG9VOEZPVmNhQzVHZ01sQkxJaU9NTXhsTDlLZWpMM0p3WkIyS2t6dmtOZjFFTFVxbzNvcVJWQlQxcGQzMk9uaE1XbUFxX0dLS0N5a3BJejJzejZab3BFemZtUzd3WXVtSEs0WEphQkU3MUVfX241SFRvWmdYbXpSSS16VkQ2M1NUZlZWV0NtbzJmdE00QmM1ZWdPcjQydHBYeF9nUVdSN1Bn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOdlV3SlRzVDlISGdtZXljQXBwNVZ4VEYwZWFqODJLUWRYZm5TX3M5RTZwMTd2TWFfdkYwSUdwWXJJNEt2X3JyTXZMOUNaTjU5dFdXSU1lSzl3SG9VOEZPVmNhQzVHZ01sQkxJaU9NTXhsTDlLZWpMM0p3WkIyS2t6dmtOZjFFTFVxbzNvcVJWQlQxcGQzMk9uaE1XbUFxX0dLS0N5a3BJejJzejZab3BFemZtUzd3WXVtSEs0WEphQkU3MUVfX241SFRvWmdYbXpSSS16VkQ2M1NUZlZWV0NtbzJmdE00QmM1ZWdPcjQydHBYeF9nUVdSN1Bn?oc=5\" target=\"_blank\">Belpointe Asset Management LLC Has $1.94 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-09-13T09:26:37+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNdDBadnVSa1dZekpjNkFGU0ctbGRsVmJ3azVhOVZBTHItNlR4WE1HZFROYzRXazdpN3g3dUowR0ttTEJIQ1NvWjlqR09Xa2VlLXlXNFJ1SS1vNVlKVTBzVGdRRWZRU05PNzNmMXZIemh6NWtlMzdhbXdPc3RvSmdkdEJWVFpXeUtMeVdMRFVVMFUxRVdJTHIwTVNSZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxNdDBadnVSa1dZekpjNkFGU0ctbGRsVmJ3azVhOVZBTHItNlR4WE1HZFROYzRXazdpN3g3dUowR0ttTEJIQ1NvWjlqR09Xa2VlLXlXNFJ1SS1vNVlKVTBzVGdRRWZRU05PNzNmMXZIemh6NWtlMzdhbXdPc3RvSmdkdEJWVFpXeUtMeVdMRFVVMFUxRVdJTHIwTVNSZw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-12T13:00:04+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "2025 Vertex Foundation Scholarship recipients: Real stories and reimagined futures - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNLTN5U0tyRE9vNThaQi1IeGJ5a2xRdFFwS2ZmRUVtR2l4SllfUGJYZU5zNGVTYnhxRHMwQmh1RWRvczJ2Y3Y5bldpOXNqNTBVRDgzcWV2R2dEZnpCQzFBQWl4eVJ6OHIzTkloNjdJYVEtbkRSWVhxY1VnUERpY2t0Z0VGcGxjcFZJTVlQYjVkdXJsOUlPdnI5VWtteDhVakU4Qk9sdkhVUzU1aUFIRW5tNQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNLTN5U0tyRE9vNThaQi1IeGJ5a2xRdFFwS2ZmRUVtR2l4SllfUGJYZU5zNGVTYnhxRHMwQmh1RWRvczJ2Y3Y5bldpOXNqNTBVRDgzcWV2R2dEZnpCQzFBQWl4eVJ6OHIzTkloNjdJYVEtbkRSWVhxY1VnUERpY2t0Z0VGcGxjcFZJTVlQYjVkdXJsOUlPdnI5VWtteDhVakU4Qk9sdkhVUzU1aUFIRW5tNQ?oc=5\" target=\"_blank\">2025 Vertex Foundation Scholarship recipients: Real stories and reimagined futures</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-09-08T13:02:54+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Citi Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $550 - 富途牛牛",
      "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNOF9lNG1fczV2dHR1U3lrdVZTcHZ0ZWZGMnlPLXFFUE5Cb2tFU1lQeUpTZzJadm1aenJsVDFnRXlucnY4ZkxUQnl5aWQtcTUxbWVpYi1WcmpScE5nMW8tYmtCZHNDZXF5Vm45R0hGNW53ODZtZnJqazJJcEdMcGs4MGpwLVRaYjdmUk4wNGJWWkhTblhVTGZubEFFdWQtb20xTHJMOVpFNFo2RGZDRDc1V054a0NQdFhnR1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiugFBVV95cUxNOF9lNG1fczV2dHR1U3lrdVZTcHZ0ZWZGMnlPLXFFUE5Cb2tFU1lQeUpTZzJadm1aenJsVDFnRXlucnY4ZkxUQnl5aWQtcTUxbWVpYi1WcmpScE5nMW8tYmtCZHNDZXF5Vm45R0hGNW53ODZtZnJqazJJcEdMcGs4MGpwLVRaYjdmUk4wNGJWWkhTblhVTGZubEFFdWQtb20xTHJMOVpFNFo2RGZDRDc1V054a0NQdFhnR1E?oc=5\" target=\"_blank\">Citi Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $550</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">富途牛牛</font>",
      "published": "2025-09-11T01:31:00+00:00",
      "source": "富途牛牛"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "Scientists who revolutionized cystic fibrosis treatment win prestigious Lasker Award - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQMTlPUDZFbXNrWWwxSThORG12d2E3bndiNXJ4UEQ4eW1UaVk2b2VuOGpsempJclBBOXI3WTVYLS1PT0tKREtWZ2pZYzFCOEo0V2xQX2hJYmpuRExvQ3Z5SUstQmloeEZOWkxsbjY0Q0gwN3FKTm1DWF8xSWtSVkM2MkVpdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxQMTlPUDZFbXNrWWwxSThORG12d2E3bndiNXJ4UEQ4eW1UaVk2b2VuOGpsempJclBBOXI3WTVYLS1PT0tKREtWZ2pZYzFCOEo0V2xQX2hJYmpuRExvQ3Z5SUstQmloeEZOWkxsbjY0Q0gwN3FKTm1DWF8xSWtSVkM2MkVpdw?oc=5\" target=\"_blank\">Scientists who revolutionized cystic fibrosis treatment win prestigious Lasker Award</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-09-11T16:16:33+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Triple-Drug Combination for Cystic Fibrosis Wins Lasker Award - the-scientist.com",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOVElvT1lXOUhGMm9UVGxYUGVEblh5Nm1qMDBrdmQtcFJCenBXNGd0TVQyZXZ3RWtzNUJsd1FwNUR3ZTdUdFZPWlJWZW44V3Z6QTdXbXppRnRSQnl0aGZ2STFVc3RueGlNcU1hdXlvYUFUTFVlay1KTy1XTjBxMjFPbzJ3ekU4b2VXYXFscEVHRjRaS051aFgxU1hVWExvdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOVElvT1lXOUhGMm9UVGxYUGVEblh5Nm1qMDBrdmQtcFJCenBXNGd0TVQyZXZ3RWtzNUJsd1FwNUR3ZTdUdFZPWlJWZW44V3Z6QTdXbXppRnRSQnl0aGZ2STFVc3RueGlNcU1hdXlvYUFUTFVlay1KTy1XTjBxMjFPbzJ3ekU4b2VXYXFscEVHRjRaS051aFgxU1hVWExvdw?oc=5\" target=\"_blank\">Triple-Drug Combination for Cystic Fibrosis Wins Lasker Award</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">the-scientist.com</font>",
      "published": "2025-09-11T13:08:43+00:00",
      "source": "the-scientist.com"
    },
    {
      "title": "Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug - Investopedia",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5\" target=\"_blank\">Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investopedia</font>",
      "published": "2025-08-05T07:00:00+00:00",
      "source": "Investopedia"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: Promising Growth and Strategic Positioning Justify Buy Rating - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOU3g4MEc1a2FVWm84OERBUHJiVy11VDRfN1NRQ05Jb3lIXzNvSmZfOGY5a19YQW9nU2hJSjR6M2RYXzVGb3U1VzBKNW9PaGwydVhXc1E4VE5yOHR2ZVRGT3FiRG5xRXJKQmktRWt5bThPU2NWR2xCNEF3UWljYmNCMmtlcDRDdHRqRDliWUM2ek1MSFVGQTJCZ1FFbnpMS0xGdUE0TUVhR0d5R1BycHVLbWdWajUzNUVfWlFPOXZ6RDBzR1dHbHlTbkRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxOU3g4MEc1a2FVWm84OERBUHJiVy11VDRfN1NRQ05Jb3lIXzNvSmZfOGY5a19YQW9nU2hJSjR6M2RYXzVGb3U1VzBKNW9PaGwydVhXc1E4VE5yOHR2ZVRGT3FiRG5xRXJKQmktRWt5bThPU2NWR2xCNEF3UWljYmNCMmtlcDRDdHRqRDliWUM2ek1MSFVGQTJCZ1FFbnpMS0xGdUE0TUVhR0d5R1BycHVLbWdWajUzNUVfWlFPOXZ6RDBzR1dHbHlTbkRR?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth and Strategic Positioning Justify Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-09-08T15:01:39+00:00",
      "source": "TipRanks"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSFE4SUNTM29jZVgzVWNDOWZ4UHU1cjFuNnQ4TG1Xak5hNjJhREVrM0xzTTUxaE1wZktyZ2N4OXVKZkFycmpLcmdGejJ4eVN2UThxOWZGLTJld2xkakt4YnpnSWFVb2RHcUkxZEdqUHVLeGdZOU9sajJ4MllETXBQT01nVVNFbmVwdW9aUXJFbXFzcXNNZjdEVTZNYTVYcTdnQzA2cXNmT3JHTlBFLWZ2UEdUT1czMm8t?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNSFE4SUNTM29jZVgzVWNDOWZ4UHU1cjFuNnQ4TG1Xak5hNjJhREVrM0xzTTUxaE1wZktyZ2N4OXVKZkFycmpLcmdGejJ4eVN2UThxOWZGLTJld2xkakt4YnpnSWFVb2RHcUkxZEdqUHVLeGdZOU9sajJ4MllETXBQT01nVVNFbmVwdW9aUXJFbXFzcXNNZjdEVTZNYTVYcTdnQzA2cXNmT3JHTlBFLWZ2UEdUT1czMm8t?oc=5\" target=\"_blank\">Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-02-11T08:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-09-12",
      "close": 394.5299987792969
    },
    "history": [
      {
        "date": "2025-09-04",
        "close": 396.92999267578125
      },
      {
        "date": "2025-09-05",
        "close": 396.1199951171875
      },
      {
        "date": "2025-09-08",
        "close": 395.25
      },
      {
        "date": "2025-09-09",
        "close": 396.4800109863281
      },
      {
        "date": "2025-09-10",
        "close": 388.54998779296875
      },
      {
        "date": "2025-09-11",
        "close": 397.3699951171875
      },
      {
        "date": "2025-09-12",
        "close": 394.5299987792969
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}